The abstract is read at the publisher; the summary is JClub's.
Quantitative late gadolinium enhancement in hypertrophic cardiomyopathy is independently linked to long-term adverse outcomes, with LGE ≥10% marking substantially higher risk in 3035 patients.
- Why it matters: Risk models in contemporary HCM use extensive LGE, but whether lower quantitative LGE thresholds add incremental prognostic value beyond established clinical and CMR markers remains uncertain.
- What they did: In a large contemporary cohort of 3035 HCM patients, Cox proportional hazards models adjusted for standard clinical and CMR variables tested %LGE, including the subgroup with LGE >10% (8%).
- The result: Over a median 8.8 years, higher %LGE predicted primary events (HR 1.05 per 1% increase, 95% CI 1.03–1.06; P<0.001), and LGE ≥10% was associated with higher composite risk, improving discrimination beyond ESC and AHA/ACC assessments.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.